MKKGY
Price
$25.77
Change
+$0.42 (+1.66%)
Updated
Sep 5 closing price
Capitalization
55.52B
66 days until earnings call
NPPNY
Price
$5.37
Change
+$0.03 (+0.56%)
Updated
Aug 7 closing price
Capitalization
1.5B
Interact to see
Advertisement

MKKGY vs NPPNY

Header iconMKKGY vs NPPNY Comparison
Open Charts MKKGY vs NPPNYBanner chart's image
Merck KGaA
Price$25.77
Change+$0.42 (+1.66%)
Volume$72.39K
Capitalization55.52B
Nippon Shinyaku
Price$5.37
Change+$0.03 (+0.56%)
Volume$1.42K
Capitalization1.5B
MKKGY vs NPPNY Comparison Chart in %
Loading...
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NPPNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MKKGY vs. NPPNY commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKKGY is a Hold and NPPNY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (MKKGY: $25.77 vs. NPPNY: $5.37)
Brand notoriety: MKKGY and NPPNY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: MKKGY: 51% vs. NPPNY: 95%
Market capitalization -- MKKGY: $55.52B vs. NPPNY: $1.5B
MKKGY [@Pharmaceuticals: Generic] is valued at $55.52B. NPPNY’s [@Pharmaceuticals: Generic] market capitalization is $1.5B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MKKGY’s FA Score shows that 1 FA rating(s) are green whileNPPNY’s FA Score has 2 green FA rating(s).

  • MKKGY’s FA Score: 1 green, 4 red.
  • NPPNY’s FA Score: 2 green, 3 red.
According to our system of comparison, NPPNY is a better buy in the long-term than MKKGY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MKKGY’s TA Score shows that 2 TA indicator(s) are bullish while NPPNY’s TA Score has 6 bullish TA indicator(s).

  • MKKGY’s TA Score: 2 bullish, 5 bearish.
  • NPPNY’s TA Score: 6 bullish, 0 bearish.
According to our system of comparison, NPPNY is a better buy in the short-term than MKKGY.

Price Growth

MKKGY (@Pharmaceuticals: Generic) experienced а +1.38% price change this week, while NPPNY (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.30%. For the same industry, the average monthly price growth was +9.43%, and the average quarterly price growth was +86.94%.

Reported Earning Dates

MKKGY is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.30% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MKKGY($55.5B) has a higher market cap than NPPNY($1.5B). MKKGY has higher P/E ratio than NPPNY: MKKGY (16.77) vs NPPNY (6.58). MKKGY YTD gains are higher at: -8.380 vs. NPPNY (-19.127). NPPNY has higher annual earnings (EBITDA): 36.5B vs. MKKGY (5.87B). NPPNY has more cash in the bank: 66B vs. MKKGY (1.57B). NPPNY has less debt than MKKGY: NPPNY (2.55B) vs MKKGY (9.4B). NPPNY has higher revenues than MKKGY: NPPNY (154B) vs MKKGY (21.2B).
MKKGYNPPNYMKKGY / NPPNY
Capitalization55.5B1.5B3,710%
EBITDA5.87B36.5B16%
Gain YTD-8.380-19.12744%
P/E Ratio16.776.58255%
Revenue21.2B154B14%
Total Cash1.57B66B2%
Total Debt9.4B2.55B369%
FUNDAMENTALS RATINGS
MKKGY vs NPPNY: Fundamental Ratings
MKKGY
NPPNY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
7
Undervalued
PROFIT vs RISK RATING
1..100
94100
SMR RATING
1..100
7018
PRICE GROWTH RATING
1..100
6263
P/E GROWTH RATING
1..100
9179
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NPPNY's Valuation (7) in the null industry is in the same range as MKKGY (23). This means that NPPNY’s stock grew similarly to MKKGY’s over the last 12 months.

MKKGY's Profit vs Risk Rating (94) in the null industry is in the same range as NPPNY (100). This means that MKKGY’s stock grew similarly to NPPNY’s over the last 12 months.

NPPNY's SMR Rating (18) in the null industry is somewhat better than the same rating for MKKGY (70). This means that NPPNY’s stock grew somewhat faster than MKKGY’s over the last 12 months.

MKKGY's Price Growth Rating (62) in the null industry is in the same range as NPPNY (63). This means that MKKGY’s stock grew similarly to NPPNY’s over the last 12 months.

NPPNY's P/E Growth Rating (79) in the null industry is in the same range as MKKGY (91). This means that NPPNY’s stock grew similarly to MKKGY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MKKGYNPPNY
RSI
ODDS (%)
N/A
Bullish Trend 7 days ago
48%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
29%
Momentum
ODDS (%)
Bearish Trend 4 days ago
54%
Bullish Trend 5 days ago
38%
MACD
ODDS (%)
Bearish Trend 4 days ago
59%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
58%
Bullish Trend 4 days ago
28%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
55%
Bullish Trend 4 days ago
25%
Advances
ODDS (%)
Bullish Trend 20 days ago
60%
N/A
Declines
ODDS (%)
Bearish Trend 14 days ago
58%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
45%
View a ticker or compare two or three
Interact to see
Advertisement
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NPPNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GWH1.370.09
+7.03%
ESS Tech
DSX1.670.03
+1.83%
Diana Shipping
RMD277.053.24
+1.18%
ResMed
CNX29.550.15
+0.51%
CNX Resources Corp
URGN18.880.08
+0.43%
UroGen Pharma Ltd

MKKGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKKGY has been loosely correlated with MKGAF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if MKKGY jumps, then MKGAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKKGY
1D Price
Change %
MKKGY100%
+1.66%
MKGAF - MKKGY
58%
Loosely correlated
+1.49%
LNTH - MKKGY
27%
Poorly correlated
+1.73%
PHCUF - MKKGY
22%
Poorly correlated
N/A
CPHI - MKKGY
22%
Poorly correlated
+16.32%
NPPNY - MKKGY
11%
Poorly correlated
N/A
More

NPPNY and

Correlation & Price change

A.I.dvisor tells us that NPPNY and MKKGY have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NPPNY and MKKGY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NPPNY
1D Price
Change %
NPPNY100%
N/A
MKKGY - NPPNY
11%
Poorly correlated
+1.66%
MEDIF - NPPNY
11%
Poorly correlated
-1.26%
OVATF - NPPNY
9%
Poorly correlated
N/A
OMID - NPPNY
1%
Poorly correlated
N/A
MVMDF - NPPNY
-1%
Poorly correlated
-9.82%
More